EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$13.23
-0.56 (-4.06%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -30.4% upside
Low Target $6.71
Average Target $9.21
High Target $14.14
Current Price $13.23
Current
$13.23
Target
$9.21
$6.71 $9.21 avg $14.14
Scenario Analysis
Bear Case
$6.71
-49.3%
Low target
Base Case
$9.21
-30.4%
Avg target
Bull Case
$14.14
+6.9%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$19.11
-30.8% from high
52-Week Low
$3.91
+238.4% from low
Target vs 52W High
$9.21
-51.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%